3rd Faculty of Medicine Charles University Ruská 87 Prague 10 Prague 100 00 Czech Republic

Institute of Computer Science of the Czech Academy of Sciences Prague Pod Vodárenskou věží 2 Prague 8 182 00 Czech Republic

National Institute of Mental Health Topolová 748 Klecany 250 67 Czech Republic

Zobrazit více v PubMed

Aday JS, Mitzkovitz CM, Bloesch EK, Davoli CC, Davis AK (2020) Long-term effects of psychedelic drugs: a systematic review. Neurosci Biobehav Rev 113:179–189. https://doi.org/10.1016/j.neubiorev.2020.03.017 PubMed DOI

Bartlett EA, DeLorenzo C, Sharma P, Yang J, Zhang M, Petkova E, Weissman M, McGrath PJ, Fava M, Ogden RT, Kurian BT, Malchow A, Cooper CM, Trombello JM, McInnis M, Adams P, Oquendo MA, Pizzagalli DA, Trivedi M, Parsey RV (2018) Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder. Neuropsychopharmacology 43(11):2221–2230. https://doi.org/10.1038/s41386-018-0122-9 PubMed DOI PMC

Beliveau V, Ganz M, Feng L, Ozenne B, Højgaard L, Fisher PM, Knudsen GM (2016) A high-resolution in vivo atlas of the human brain’s serotonin system. J Neurosci 37(1):120–128. https://doi.org/10.1523/jneurosci.2830-16.2016 DOI

Berman MG, Peltier S, Nee DE, Kross E, Deldin PJ, Jonides J (2011) Depression, rumination and the default network. Soc Cogn Affect Neurosci 6(5):548–555. https://doi.org/10.1093/scan/nsq080 PubMed DOI

Bouso JC, Palhano-Fontes F, Rodríguez-Fornells A, Ribeiro S, Sanches R, Crippa JAS, Hallak JEC, de Araujo DB, Riba J (2015) Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. Eur Neuropsychopharmacol 25(4):483–492. https://doi.org/10.1016/j.euroneuro.2015.01.008 PubMed DOI

Bravermanová A, Viktorinová M, Tylš F, Novák T, Androvičová R, Korčák J, Páleníček T (2018) Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing—study on P300 and mismatch negativity in healthy volunteers. Psychopharmacology 235(2):491–503. https://doi.org/10.1007/s00213-017-4807-2 PubMed DOI

Butcher JN, Dahlstrom WG, Graham JR, Tellegen A, Kaemmer B (2001) MMPI-2: Manual for administration, scoring, and interpretation, Rev. ed. University of Minnesota Press

Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, Tyacke RJ, Leech R, Malizia AL, Murphy K, Hobden P, Evans J, Feilding A, Wise RG, Nutt DJ (2012) Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci U S A 109(6):2138–2143. https://doi.org/10.1073/pnas.1119598109 PubMed DOI PMC

Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, Chialvo DR, Nutt DJ (2014) The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Front Hum Neurosci 8:20 PubMed DOI PMC

Cheng W, Rolls ET, Qiu J, Yang D, Ruan H, Wei D, Zhao L, Meng J, Xie P, Feng J (2018) Increased functional connectivity of the posterior cingulate cortex with the lateral orbitofrontal cortex in depression. Transl Psychiatry 8(1):90. https://doi.org/10.1038/s41398-018-0139-1 PubMed DOI PMC

Dittrich A (1998) The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry 31(S2):80–84. https://doi.org/10.1055/s-2007-979351 PubMed DOI

Drevets WC, Price JL, Simpson JR, Todd RD, Reich T, Vannier M, Raichle ME (1997) Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386(6627):824–827. https://doi.org/10.1038/386824a0 PubMed DOI

Dudysová D, Janků K, Šmotek M, Saifutdinova E, Kopřivová J, Bušková J, Horáček J (2020) The effects of daytime psilocybin administration on sleep: implications for antidepressant action. Front Pharmacol 11. https://doi.org/10.3389/fphar.2020.602590

Fischl B (2012) FreeSurfer. Neuroimage 62(2):774–781 PubMed DOI

Johnson M, Richards W, Griffiths R (2008) Human hallucinogen research: guidelines for safety. J Psychopharmacol 22(6):603–620. https://doi.org/10.1177/0269881108093587 PubMed DOI PMC

Lewis CR, Preller KH, Braden BB, Riecken C, Vollenweider FX (2020) Rostral anterior cingulate thickness predicts the emotional psilocybin experience. Biomedicines 8(2):34. https://doi.org/10.3390/biomedicines8020034 PubMed DOI PMC

Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ (2013) Broadband cortical desynchronization underlies the human psychedelic state. J Neurosci 33(38):15171–15183. https://doi.org/10.1523/JNEUROSCI.2063-13.2013 PubMed DOI PMC

Nemati S, Abdallah CG (2020) Increased cortical thickness in patients with major depressive disorder following antidepressant treatment. Chronic Stress 4:2470547019899962. https://doi.org/10.1177/2470547019899962 PubMed DOI PMC

Nichols DE (2016) Psychedelics. Pharmacol Rev 68(2):264–355. https://doi.org/10.1124/pr.115.011478 PubMed DOI PMC

Nikolič M, Viktorin V, Zach P, Tylš F, Dudysová D, Janků K, Kopřivová J, Kuchař M, Brunovský M, Horáček J, Páleníček T (2023) Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis. Eur Neuropsychopharmacol 74:78–88. https://doi.org/10.1016/j.euroneuro.2023.04.019 PubMed DOI

Preller KH, Vollenweider FX (2018) Phenomenology, structure, and dynamic of psychedelic states. Curr Top Behav Neurosci 36:221–256. https://doi.org/10.1007/7854_2016_459 PubMed DOI

Rolls ET, Cheng W, Gong W, Qiu J, Zhou C, Zhang J, Lv W, Ruan H, Wei D, Cheng K, Meng J, Xie P, Feng J (2019) Functional connectivity of the anterior cingulate cortex in depression and in health. Cereb Cortex 29(8):3617–3630. https://doi.org/10.1093/cercor/bhy236 PubMed DOI

Roseman L, Nutt DJ, Carhart-Harris RL (2018) Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Front Pharmacol 8:974. https://doi.org/10.3389/fphar.2017.00974 PubMed DOI PMC

Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22–33 PubMed

Studerus E, Gamma A, Vollenweider FX (2010) Psychometric evaluation of the altered states of consciousness rating scale (OAV). PLoS One 5(8):e12412. https://doi.org/10.1371/journal.pone.0012412 PubMed DOI PMC

Studerus E, Kometer M, Hasler F, Vollenweider FX (2011) Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. J Psychopharmacol 25(11):1434–1452. https://doi.org/10.1177/0269881110382466 PubMed DOI

Tylš F, Páleníček T, Horáček J (2014) Psilocybin – summary of knowledge and new perspectives. Eur Neuropsychopharmacol 24(3):342–356. https://doi.org/10.1016/j.euroneuro.2013.12.006 PubMed DOI

Viktorin V, Griškova-Bulanova I, Voicikas A, Dojčánová D, Zach P, Bravermanová A, Andrashko V, Tylš F, Korčák J, Viktorinová M, Koudelka V, Hájková K, Kuchař M, Horáček J, Brunovský M, Páleníček T (2022) Psilocybin—mediated attenuation of gamma band auditory steady-state responses (ASSR) is driven by the intensity of cognitive and emotional domains of psychedelic experience. J Pers Med 12(6):1004. https://doi.org/10.3390/jpm12061004 PubMed DOI PMC

Vollenweider FX, Kometer M (2010) The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci 11(9):642–651. https://doi.org/10.1038/nrn2884 PubMed DOI

Yaden DB, Griffiths RR (2020) The subjective effects of psychedelics are necessary for their enduring therapeutic effects. ACS Pharmacol Transl Sci. https://doi.org/10.1021/acsptsci.0c00194 PubMed DOI PMC